title: Preparation and Characterization of Amylose Inclusion Complexes for Drug Delivery Applications.
abstract: Amylose complexes with nimesulide (NMS) and praziquantel (PZQ) were prepared by a simple and low cost method, so that high yield (>57%) and drug content (up to 68.16%) were achieved. The influence of drug:polymer ratio, temperature, and presence of palmitic acid on the complexes properties was evaluated. Differential scanning calorimetry, X-ray diffraction, and nuclear magnetic resonance data evidenced the drug-polymer interaction and the formation of inclusion complexes with semi-crystalline structures related to type II complexes. The drug release rates from complexes were lowered in acid media (pH 1.2) and phosphate buffer (pH 6.9). The presence of pancreatin promoted a significant acceleration of the release rates of both drugs, evidencing the enzymatic degradability of these complexes. The highest enzymatic resistance of PZQ1:30PA60°C complex makes the release time longer and the full release of PZQ in phosphate buffer with pancreatin occurred at 240 min, whereas the complexes with NMS and PZQ1:5PA90°C did it in 60 min. According to the Weibull model, the drug release process in media without enzyme occurred by complex mechanisms involving diffusion, swelling, and erosion. In media containing pancreatin, generally, the better correlation was with the first order, evidencing the acceleration of the release rates of drugs in the early stages of the test, due to enzymatic degradation.
authors.forename: Fernanda M
authors.initials: FM
authors.lastname: Carbinatto
authors.forename: Tatiana S
authors.initials: TS
authors.lastname: Ribeiro
authors.forename: Luiz Alberto
authors.initials: LA
authors.lastname: Colnago
authors.forename: Raul Cesar
authors.initials: RC
authors.lastname: Evangelista
authors.forename: Beatriz S F
authors.initials: BS
authors.lastname: Cury
mesh_terms: D000688:Amylose / Q000008:administration & dosage* / Q000737:chemistry*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000493:pharmacokinetics; D000980:Antiplatyhelmintic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D002021:Buffers; D002151:Calorimetry; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems; D007700:Kinetics; D019308:Palmitic Acid / Q000737:chemistry; D010194:Pancreatin / Q000737:chemistry; D011223:Praziquantel / Q000008:administration & dosage / Q000493:pharmacokinetics; D013449:Sulfonamides / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000980:Antiplatyhelmintic Agents; D002021:Buffers; D003692:Delayed-Action Preparations; D013449:Sulfonamides; D019308:Palmitic Acid; D011223:Praziquantel; D010194:Pancreatin; D000688:Amylose; C012655:nimesulide